Correction: Discriminating established cardiovascular disease using a novel multiterritory ultrasound plaque burden measure (wTPT): findings from the P-SONAR study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Utilizing a Novel Multiterritory Ultrasound Plaque Burden Metric (wTPT) to Differentiate Established Cardiovascular Disease: Insights from the P-SONAR Study

  • By

  • Gunnar Austad

  • Jonn Terje Geitung

  • Owen Thomas

  • Serena Tonstad

  • October 5, 2026

Share

Objective:

To correct inaccuracies in the presentation of figures in the original publication.

Key Findings:
  • Figures 1, 3, and the Graphical Abstract were presented incorrectly in the original publication.
  • Corrected versions of these figures have been provided.
Interpretation:

The correction addresses inaccuracies in the visual data representation of the figures.

Conclusion:

The article includes corrected figures to ensure accurate visual representation.

Sources:

Original Source(s)

Correction: Discriminating established cardiovascular disease using a novel multiterritory ultrasound plaque burden measure (wTPT): findings from the P-SONAR study

  • by Gunnar Austad, Jonn Terje Geitung, Owen Thomas, Serena Tonstad

  • October 5, 2026

Related Content

The merits of the prognostic nutritional index and neutrophil-to-lymphocyte ratio in predicting outcomes of coronary artery bypass grafting: a retrospective cohort study

Data Analytics Dashboard for Pre–Magnetic Resonance Imaging Safety Screening of Implantable Medical Devices

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.